1. Home
  2. PTHL vs OPXS Comparison

PTHL vs OPXS Comparison

Compare PTHL & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • OPXS
  • Stock Information
  • Founded
  • PTHL 1998
  • OPXS 1987
  • Country
  • PTHL China
  • OPXS United States
  • Employees
  • PTHL N/A
  • OPXS N/A
  • Industry
  • PTHL
  • OPXS Electronic Components
  • Sector
  • PTHL
  • OPXS Technology
  • Exchange
  • PTHL Nasdaq
  • OPXS Nasdaq
  • Market Cap
  • PTHL 43.1M
  • OPXS 45.6M
  • IPO Year
  • PTHL 2024
  • OPXS N/A
  • Fundamental
  • Price
  • PTHL $3.00
  • OPXS $5.90
  • Analyst Decision
  • PTHL
  • OPXS
  • Analyst Count
  • PTHL 0
  • OPXS 0
  • Target Price
  • PTHL N/A
  • OPXS N/A
  • AVG Volume (30 Days)
  • PTHL 33.4K
  • OPXS 25.6K
  • Earning Date
  • PTHL 02-11-2025
  • OPXS 02-10-2025
  • Dividend Yield
  • PTHL N/A
  • OPXS N/A
  • EPS Growth
  • PTHL N/A
  • OPXS 42.37
  • EPS
  • PTHL N/A
  • OPXS 0.61
  • Revenue
  • PTHL $572,291.00
  • OPXS $35,225,000.00
  • Revenue This Year
  • PTHL N/A
  • OPXS N/A
  • Revenue Next Year
  • PTHL N/A
  • OPXS N/A
  • P/E Ratio
  • PTHL N/A
  • OPXS $9.70
  • Revenue Growth
  • PTHL 2.32
  • OPXS 23.22
  • 52 Week Low
  • PTHL $1.96
  • OPXS $5.72
  • 52 Week High
  • PTHL $6.45
  • OPXS $10.30
  • Technical
  • Relative Strength Index (RSI)
  • PTHL N/A
  • OPXS 34.39
  • Support Level
  • PTHL N/A
  • OPXS $5.91
  • Resistance Level
  • PTHL N/A
  • OPXS $6.20
  • Average True Range (ATR)
  • PTHL 0.00
  • OPXS 0.35
  • MACD
  • PTHL 0.00
  • OPXS -0.03
  • Stochastic Oscillator
  • PTHL 0.00
  • OPXS 15.25

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.

Share on Social Networks: